3′ end mRNA processing: molecular mechanisms and implications for health and disease
暂无分享,去创建一个
[1] W. Boelens,et al. The human U1A snRNP protein regulates polyadenylation via a direct interaction with poly(A) polymerase , 1994, Cell.
[2] C. Prives,et al. Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non‐consensus sites , 1998, The EMBO journal.
[3] J. Steitz,et al. Association with terminal exons in pre-mRNAs: a new role for the U1 snRNP? , 1993, Genes & development.
[4] K. Lindblad-Toh,et al. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals , 2005, Nature.
[5] Z. Dominski,et al. The Polyadenylation Factor CPSF-73 Is Involved in Histone-Pre-mRNA Processing , 2005, Cell.
[6] T. Maniatis,et al. An extensive network of coupling among gene expression machines , 2002, Nature.
[7] Jing Zhao,et al. Formation of mRNA 3′ Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis , 1999, Microbiology and Molecular Biology Reviews.
[8] D. Cooper,et al. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview , 2006, Human Genetics.
[9] J. Manley,et al. Cotranscriptional processes and their influence on genome stability. , 2006, Genes & development.
[10] J. Manley,et al. Mechanism and regulation of mRNA polyadenylation. , 1997, Genes & development.
[11] D. Black. Protein Diversity from Alternative Splicing A Challenge for Bioinformatics and Post-Genome Biology , 2000, Cell.
[12] D. Shutt,et al. Functional Coupling of Cleavage and Polyadenylation with Transcription of mRNA* , 2005, Journal of Biological Chemistry.
[13] G. Luo,et al. A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators. , 2006, Molecular biology of the cell.
[14] Bin Tian,et al. A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.
[15] M. Losekoot,et al. A novel polyadenylation signal mutation in the alpha 2-globin gene causing alpha thalassaemia. , 1994, British Journal of Haematology.
[16] J. Wilusz,et al. Cleavage site determinants in the mammalian polyadenylation signal. , 1995, Nucleic acids research.
[17] A. Ristimäki,et al. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. , 1996, The Biochemical journal.
[18] M. Rosbash,et al. Nuclear RNA export. , 1998, Genes & development.
[19] H. Kazazian,et al. Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] D. Cox,et al. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer , 2004, British Journal of Cancer.
[21] G. Gilmartin. Eukaryotic mRNA 3' processing: a common means to different ends. , 2005, Genes & development.
[22] R. Krug,et al. Crucial role of CA cleavage sites in the cap‐snatching mechanism for initiating viral mRNA synthesis , 2003, The EMBO journal.
[23] H. Lou,et al. Alternative RNA processing--its role in regulating expression of calcitonin/calcitonin gene-related peptide. , 1998, The Journal of endocrinology.
[24] Nick Proudfoot,et al. New perspectives on connecting messenger RNA 3' end formation to transcription. , 2004, Current opinion in cell biology.
[25] M. Hentze,et al. 3′ End Processing of the Prothrombin mRNA in Thrombophilia , 2006, Acta Haematologica.
[26] R. Krug,et al. Influenza A virus NS1 protein targetspoly(A)‐binding protein II of the cellular 3′‐end processing machinery , 1999, The EMBO journal.
[27] N. Bazan,et al. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic alzheimer neocortex , 1997, Journal of neuroscience research.
[28] P. Bork,et al. Splicing factors stimulate polyadenylation via USEs at non‐canonical 3′ end formation signals , 2007, The EMBO journal.
[29] G. Pangalis,et al. Polyadenylic acid polymerase activity in normal and leukemic human leukocytes. , 1984, Cancer research.
[30] K. Murthy,et al. The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3'-end formation. , 1995, Genes & development.
[31] J. Manley,et al. The BARD1-CstF-50 Interaction Links mRNA 3′ End Formation to DNA Damage and Tumor Suppression , 2001, Cell.
[32] J. Rogers,et al. Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathways , 1980, Cell.
[33] A. Phelan,et al. Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing , 1992, Journal of virology.
[34] M. Akısü,et al. Effect of Dietary n–3 Fatty Acids on Hypoxia-Induced Necrotizing Enterocolitis in Young Mice , 1998, Neonatology.
[35] S. Cohen,et al. Mixed Messages in Early Development , 2006, Science.
[36] C. P. Morris,et al. Importance of the glycosylation and polyadenylation variants in metachromatic leukodystrophy pseudodeficiency phenotype. , 1998, Human molecular genetics.
[37] Hanno Langen,et al. Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3' end processing and splicing. , 2006, Molecular cell.
[38] T. Maniatis,et al. Amplification and characterization of a β-globin gene synthesized in vitro , 1976, Cell.
[39] J. Tam,et al. A novel function for the U2AF 65 splicing factor in promoting pre‐mRNA 3′‐end processing , 2002, EMBO reports.
[40] O. Rozenblatt-Rosen,et al. The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination. , 2007, Genes & development.
[41] K. Murthy,et al. Interaction between the U1 snRNP-A protein and the 160-kD subunit of cleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro. , 1996, Genes & development.
[42] Richard Treisman,et al. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences , 1988, Nature.
[43] J. Manley,et al. RNA polymerase II is an essential mRNA polyadenylation factor , 1998, Nature.
[44] S. Buratowski,et al. Connections between mRNA 3' end processing and transcription termination. , 2005, Current opinion in cell biology.
[45] B. Graveley,et al. RNA structure is a critical determinant of poly(A) site recognition by cleavage and polyadenylation specificity factor , 1996, Molecular and cellular biology.
[46] M. Edmonds,et al. A history of poly A sequences: from formation to factors to function. , 2002, Progress in nucleic acid research and molecular biology.
[47] R. Duronio,et al. Histone mRNA expression: multiple levels of cell cycle regulation and important developmental consequences. , 2002, Current opinion in cell biology.
[48] W. Keller,et al. Last but not least: regulated poly(A) tail formation. , 1999 .
[49] D. Cooper,et al. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants , 2006, Human Genetics.
[50] M. Rosbash,et al. The yeast splicing factor Mud13p is a commitment complex component and corresponds to CBP20, the small subunit of the nuclear cap-binding complex. , 1996, Genes & development.
[51] M. Losekoot,et al. A novel polyadenylation signal mutation in the α2‐globin gene causing α thalassaemia , 1994 .
[52] D. Price,et al. Cotranscriptional Processing of Drosophila Histone mRNAs , 2003, Molecular and Cellular Biology.
[53] M. Hentze,et al. The prothrombin 20209 C→T mutation in Jewish‐Moroccan Caucasians: molecular analysis of gain‐of‐function of 3′ end processing , 2006, Journal of thrombosis and haemostasis : JTH.
[54] A. Kerstan,et al. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. , 1999, Immunity.
[55] J. Hirsh,et al. How we diagnose and treat deep vein thrombosis. , 2002, Blood.
[56] R. Krug,et al. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. , 1998, Molecular cell.
[57] J. Manley,et al. Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms , 1996, Molecular and cellular biology.
[58] S. Buratowski,et al. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3' end processing. , 2004, Molecular cell.
[59] P. Strisciuglio,et al. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency , 2003, Journal of medical genetics.
[60] J. Alwine,et al. The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Manley,et al. Identification and Functional Characterization of Neo-Poly(A) Polymerase, an RNA Processing Enzyme Overexpressed in Human Tumors , 2022 .
[62] J. Bonner,et al. Differentiation , 1968, Nature.
[63] K. Tokunaga,et al. Polymorphisms of human CD19 gene: possible association with susceptibility to systemic lupus erythematosus in Japanese , 2002, Genes and Immunity.
[64] I. Mattaj,et al. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. , 1998, Molecular cell.
[65] M. Calzado,et al. Human Immunodeficiency Virus Type 1 Tat Increases the Expression of Cleavage and Polyadenylation Specificity Factor 73-Kilodalton Subunit Modulating Cellular and Viral Expression , 2004, Journal of Virology.
[66] N. Sonenberg,et al. The mRNA closed-loop model: the function of PABP and PABP-interacting proteins in mRNA translation. , 2001, Cold Spring Harbor symposia on quantitative biology.
[67] Bin Tian,et al. Alternative polyadenylation of cyclooxygenase-2 , 2005, Nucleic acids research.
[68] N. Proudfoot,et al. Recruitment of a Basal Polyadenylation Factor by the Upstream Sequence Element of the Human Lamin B2 Polyadenylation Signal , 2000, Molecular and Cellular Biology.
[69] D. Black. Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.
[70] H. Grönberg,et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. , 2004, Cancer research.
[71] A. Scorilas,et al. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer. , 2000, Cancer research.
[72] W. Marzluff,et al. Introns in histone genes alter the distribution of 3' ends. , 1990, Nucleic acids research.
[73] M. Hentze,et al. Starting at the Beginning, Middle, and End: Translation Initiation in Eukaryotes , 1997, Cell.
[74] Syuzo Kaneko,et al. Terminating the transcript: breaking up is hard to do. , 2006, Genes & development.
[75] A. Harris,et al. Prevalence of common mutations in the arylsulphatase A gene in metachromatic leukodystrophy patients diagnosed in Britain , 1993, Human Genetics.
[76] L. Tong,et al. Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease , 2006, Nature.
[77] R. Sandri-Goldin,et al. A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing. , 1992, Genes & development.
[78] I. Kanazawa,et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy , 1998, Nature.
[79] K. von Figura,et al. Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[80] F C Kafatos,et al. Amplification and characterization of a beta-globin gene synthesized in vitro. , 1976, Cell.
[81] E. Wahle,et al. Structure and function of poly(A) binding proteins. , 2004, Biochimica et biophysica acta.
[82] H. Shin,et al. Polymorphisms in fatty acid-binding protein-3 (FABP3) - putative association with type 2 diabetes mellitus. , 2003, Human mutation.
[83] S. Orkin,et al. Thalassemia due to a mutation in the cleavage‐polyadenylation signal of the human beta‐globin gene. , 1985, The EMBO journal.
[84] D. Shweiki,et al. A novel function for alternative polyadenylation as a rescue pathway from NMD surveillance. , 2007, Biochemical and biophysical research communications.
[85] B. Blencowe,et al. An Evolutionarily Conserved Role for SRm160 in 3′-End Processing That Functions Independently of Exon Junction Complex Formation* , 2003, Journal of Biological Chemistry.
[86] J. McLauchlan,et al. Herpes simplex virus induces a processing factor that stimulates poly(A) site usage , 1989, Cell.
[87] B. Coupar,et al. A common mechanism for the synthesis of membrane and secreted immunoglobulin α, γ and μ chains , 1982, Nature.
[88] R. Compans,et al. Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. , 1971, Virology.
[89] M. Hentze,et al. The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. , 2004, Blood.
[90] S. Jacob,et al. Antibodies against nuclear poly(A) polymerases in rheumatic autoimmune diseases , 2004, Journal of Clinical Immunology.
[91] C. Shin,et al. Cell signalling and the control of pre-mRNA splicing , 2004, Nature Reviews Molecular Cell Biology.
[92] C. C. Spaargaren-van Riel,et al. G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3′‐end formation , 2004, Journal of thrombosis and haemostasis : JTH.
[93] M. Hentze,et al. Nonsense-mediated decay approaches the clinic , 2004, Nature Genetics.
[94] S. Akman,et al. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. , 1995, Cancer research.
[95] D. Rubinsztein,et al. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. , 2006, Human molecular genetics.
[96] K. Venkataraman,et al. Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition. , 2005, Genes & development.
[97] Michael Hampsey,et al. Tails of Intrigue Phosphorylation of RNA Polymerase II Mediates Histone Methylation , 2003, Cell.
[98] S. Reis,et al. Genetic Variation in Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 (LOX1) Gene and the Risk of Coronary Artery Disease , 2003, Circulation.
[99] R. Russell,et al. Animal MicroRNAs Confer Robustness to Gene Expression and Have a Significant Impact on 3′UTR Evolution , 2005, Cell.
[100] M. Wollerton,et al. Upstream sequence elements enhance poly(A) site efficiency of the C2 complement gene and are phylogenetically conserved. , 1995, The EMBO journal.
[101] A. Schambach,et al. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[102] Shun–ichi Kobayashi. Tokyo campus rising , 1998, Nature.
[103] Hans D. Ochs,et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome , 2001, Immunogenetics.
[104] C. Langefeld,et al. Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1 alpha expression. , 2003, Kidney international.
[105] I. Mattaj,et al. The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. , 2000, Genes & development.
[106] R. Desnick,et al. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[107] A. Furger,et al. Integrating mRNA Processing with Transcription , 2002, Cell.
[108] R. Krug,et al. The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. , 2001, RNA.
[109] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[110] M. Philippe,et al. Poly(A)-Binding Protein Acts in Translation Termination via Eukaryotic Release Factor 3 Interaction and Does Not Influence [PSI+] Propagation , 2002, Molecular and Cellular Biology.
[111] A. Jacobson,et al. Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression , 2003, Genome Biology.
[112] Ed Hurt,et al. A Conserved mRNA Export Machinery Coupled to pre-mRNA Splicing , 2002, Cell.
[113] L. Minvielle-Sebastia,et al. mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. , 1999, Current opinion in cell biology.
[114] S. DeKosky,et al. Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer’s disease , 2003, Journal of medical genetics.
[115] W. Keller,et al. Human Fip1 is a subunit of CPSF that binds to U‐rich RNA elements and stimulates poly(A) polymerase , 2004, The EMBO journal.
[116] S. Jacob,et al. Polyadenylate polymerases from normal and cancer cells and their potential role in messenger RNA processing: a review. , 1989, Cancer research.
[117] B. Tian,et al. Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. , 2005, RNA.
[118] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[119] M. Spitz,et al. Thymidylate Synthase 5′- and 3′-Untranslated Region Polymorphisms Associated with Risk and Progression of Squamous Cell Carcinoma of the Head and Neck , 2004, Clinical Cancer Research.
[120] J. Steitz,et al. Symplekin and multiple other polyadenylation factors participate in 3'-end maturation of histone mRNAs. , 2005, Genes & development.
[121] Lung-Ji Chang,et al. RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy , 2002, Journal of Virology.
[122] Jiri Bartek,et al. Cell-cycle checkpoints and cancer , 2004, Nature.
[123] J. Manley,et al. RNA polymerase II and the integration of nuclear events. , 2000, Genes & development.
[124] D. Gautheret,et al. Sequence determinants in human polyadenylation site selection , 2003, BMC Genomics.
[125] M. Wickens,et al. Poly (A) polymerases in the nucleus and cytoplasm of frog oocytes: dynamic changes during oocyte maturation and early development. , 1995, RNA.
[126] J. Zehnder,et al. Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation. , 2003, The Journal of molecular diagnostics : JMD.
[127] E. Wahle,et al. The mechanism of 3' cleavage and polyadenylation of eukaryotic pre-mRNA. , 1997, Progress in nucleic acid research and molecular biology.
[128] J. Gelfand,et al. Generation of a tropoelastin mRNA variant by alternative polyadenylation site selection in sun-damaged human skin and ultraviolet B-irradiated fibroblasts. , 1998, Biochemical and biophysical research communications.
[129] G. Utermann,et al. The 342‐kb deletion in GJB6 is not present in patients with non‐syndromic hearing loss from Austria , 2003, Human mutation.
[130] C. McGuigan,et al. A nuclear cap-binding complex facilitates association of U1 snRNP with the cap-proximal 5' splice site. , 1996, Genes & development.
[131] G. Bouma,et al. A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion , 2002, Genes and Immunity.
[132] J. Manley,et al. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. , 1998, Molecular cell.
[133] Tyra Hall-Pogar,et al. Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR. , 2007, RNA.
[134] Sita Awasthi,et al. Association of polyadenylation cleavage factor I with U1 snRNP. , 2003, RNA.
[135] H. Moses,et al. Effect of cell proliferation on levels and diversity of poly(A)-containing mRNA , 1976, Cell.
[136] S. Goodbourn,et al. Alpha-thalassaemia caused by a polyadenylation signal mutation. , 1983, Nature.
[137] S. Gunderson,et al. Regulation of nuclear poly(A) addition controls the expression of immunoglobulin M secretory mRNA , 2001, The EMBO journal.
[138] J. Houwing-Duistermaat,et al. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. , 2005, Blood.
[139] T. Marr,et al. Computational analysis of 3'-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat. , 2005, Genome research.
[140] J. Rogers,et al. Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin μ chain , 1980, Cell.
[141] S. Thein,et al. Detection of prothrombin gene polymorphism at position 20209 (PT20209C/T): Pilot study in a black population in the United Kingdom , 2005, Thrombosis and Haemostasis.
[142] B. Blencowe,et al. SRm160 Splicing Coactivator Promotes Transcript 3′-End Cleavage , 2002, Molecular and Cellular Biology.
[143] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[144] T. Tsukahara,et al. The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression. , 2001, Human molecular genetics.
[145] Y. Miura,et al. Polyadenylic acid polymerase activity in chronic myelogenous leukemia. , 1990, Leukemia research.
[146] C. Langefeld,et al. Association of an IL-1A 3′UTR polymorphism with end-stage renal disease and IL-1α expression , 2003 .
[147] A. Scorilas. Polyadenylate Polymerase (PAP) and 3' End pre-mRNA Processing: Function, Assays, and Association with Disease , 2002, Critical reviews in clinical laboratory sciences.
[148] L. Paillard,et al. AU-rich elements and associated factors: are there unifying principles? , 2006, Nucleic acids research.
[149] Anton J. Enright,et al. Zebrafish MiR-430 Promotes Deadenylation and Clearance of Maternal mRNAs , 2006, Science.
[150] William Ritchie,et al. Differential Repression of Alternative Transcripts: A Screen for miRNA Targets , 2006, PLoS Comput. Biol..
[151] J. Manley,et al. The Polyadenylation Factor CstF-64 Regulates Alternative Processing of IgM Heavy Chain Pre-mRNA during B Cell Differentiation , 1996, Cell.
[152] B. Graveley. Alternative splicing: increasing diversity in the proteomic world. , 2001, Trends in genetics : TIG.
[153] S. Groshen,et al. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer , 2004, British Journal of Cancer.
[154] David Baltimore,et al. Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends , 1980, Cell.
[155] C. Baker,et al. An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels , 1991, Journal of virology.
[156] U. Pendurthi,et al. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[157] A. J. Lopez,et al. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. , 1998, Annual review of genetics.
[158] L. Maquat. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics , 2004, Nature Reviews Molecular Cell Biology.
[159] Niseema D. Pachikara,et al. U1A Inhibits Cleavage at the Immunoglobulin M Heavy-Chain Secretory Poly(A) Site by Binding between the Two Downstream GU-Rich Regions , 2004, Molecular and Cellular Biology.
[160] Y. Xia,et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. , 1993, Archives of biochemistry and biophysics.
[161] R. Bertina,et al. Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio , 2007 .
[162] Peter Marynen,et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. , 2003, The New England journal of medicine.
[163] B. Brais,et al. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. , 2000, Human molecular genetics.
[164] W. Keller,et al. An interaction between U2AF 65 and CF Im links the splicing and 3′ end processing machineries , 2006, The EMBO journal.
[165] R. Kraaijenhagen,et al. Clinical Expression of a Rare β-Globin Gene Mutation Co-Inherited with Haemoglobin E-Disease , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[166] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[167] Kirk M Brown,et al. A mechanism for the regulation of pre-mRNA 3' processing by human cleavage factor Im. , 2003, Molecular cell.
[168] M. Hentze,et al. Nonsense-mediated mRNA decay: from vacuum cleaner to Swiss army knife , 2004, Genome Biology.
[169] C. Kattamis,et al. Two novel polyadenylation mutations leading to β+‐thalassaemia , 1990 .
[170] William F Marzluff,et al. Metazoan replication-dependent histone mRNAs: a distinct set of RNA polymerase II transcripts. , 2005, Current opinion in cell biology.
[171] S. Rose,et al. In vitro polyadenylation is stimulated by the presence of an upstream intron. , 1990, Genes & development.
[172] C. Prives,et al. Cell-cycle related regulation of poly(A) polymerase by phosphorylation , 1996, Nature.
[173] Hua-Lin Zhou,et al. Hu Proteins Regulate Polyadenylation by Blocking Sites Containing U-rich Sequences* , 2007, Journal of Biological Chemistry.
[174] B. Coupar,et al. A common mechanism for the synthesis of membrane and secreted immunoglobulin alpha, gamma and mu chains. , 1982, Nature.
[175] C. Milcarek,et al. Elevated Levels of the 64-kDa Cleavage Stimulatory Factor (CstF-64) in Lipopolysaccharide-stimulated Macrophages Influence Gene Expression and Induce Alternative Poly(A) Site Selection* , 2005, Journal of Biological Chemistry.
[176] J. Rommens,et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy , 1998, Nature Genetics.
[177] R. Bertina,et al. Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio. , 2007, Journal of thrombosis and haemostasis : JTH.
[178] J. Wilusz,et al. hnRNP F Influences Binding of a 64-Kilodalton Subunit of Cleavage Stimulation Factor to mRNA Precursors in Mouse B Cells , 2001, Molecular and Cellular Biology.
[179] K. Ryan,et al. Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease. , 2004, RNA.
[180] A. Phelan,et al. Regulation of herpes simplex virus poly (A) site usage and the action of immediate-early protein IE63 in the early-late switch , 1996, Journal of virology.
[181] Marieke,et al. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene , 1992, Molecular and cellular biology.
[182] J. Manley,et al. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. , 1999, Science.
[183] B. Dallapiccola,et al. An ATG repeat in the 3'-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. , 2002, The Journal of clinical endocrinology and metabolism.
[184] A. Shyu,et al. The Double Lives of Shuttling mRNA Binding Proteins , 2000, Cell.
[185] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[186] Matthias W. Hentze,et al. Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia , 2001, Nature Genetics.
[187] B. Graveley,et al. CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition. , 1995, Genes & development.
[188] P. Klenerman,et al. Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection , 2002, Genes and Immunity.
[189] B. Kosova,et al. Budd–Chiari syndrome in a patient heterozygous for the point mutation C20221T of the prothrombin gene , 2003, Journal of thrombosis and haemostasis : JTH.
[190] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[191] M. Hentze,et al. A Perfect Message RNA Surveillance and Nonsense-Mediated Decay , 1999, Cell.
[192] D. Bell,et al. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. , 1995, Cancer research.
[193] K. Mui,et al. Nuclear polyadenylate polymerase activity in the brain of seizure‐prone EL mice , 1997, Psychiatry and clinical neurosciences.
[194] Bharat Gawande,et al. Drosophila Sex‐lethal protein mediates polyadenylation switching in the female germline , 2006, The EMBO journal.
[195] M. Lotze,et al. Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transition. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[196] D. J. Weatherall,et al. Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias , 2001, Nature Reviews Genetics.
[197] R. Krug,et al. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. , 1994, Genes & development.
[198] I. Mattaj,et al. Involvement of the carboxyl terminus of vertebrate poly(A) polymerase in U1A autoregulation and in the coupling of splicing and polyadenylation. , 1997, Genes & development.
[199] A. Beloso,et al. Influenza virus NS1 protein inhibits pre‐mRNA splicing and blocks mRNA nucleocytoplasmic transport. , 1994, The EMBO journal.
[200] T. Huisman,et al. Two novel polyadenylation mutations leading to beta(+)-thalassemia. , 1990, British journal of haematology.
[201] B. Dunn. Computational Analysis , 2007 .
[202] W. Guo,et al. Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. , 2004, Carcinogenesis.
[203] A. Weiner,et al. E Pluribus Unum: 3' end formation of polyadenylated mRNAs, histone mRNAs, and U snRNAs. , 2005, Molecular cell.
[204] G. Edwalds-Gilbert,et al. Alternative poly(A) site selection in complex transcription units: means to an end? , 1997, Nucleic acids research.
[205] C. Croce,et al. miRNAs, Cancer, and Stem Cell Division , 2005, Cell.
[206] L. Minvielle-Sebastia,et al. A comparison of mammalian and yeast pre-mRNA 3'-end processing. , 1997, Current opinion in cell biology.
[207] Jeffrey Wilusz,et al. Upstream Elements Present in the 3′-Untranslated Region of Collagen Genes Influence the Processing Efficiency of Overlapping Polyadenylation Signals* , 2002, The Journal of Biological Chemistry.
[208] L. Wolpert. Developmental Biology , 1968, Nature.
[209] M. Buchwald,et al. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9 , 1992, Nature Genetics.
[210] R. Desnick,et al. Fabry disease: novel alpha-galactosidase A 3'-terminal mutations result in multiple transcripts due to aberrant 3'-end formation. , 2003, American journal of human genetics.
[211] M. Wollerton,et al. The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms. , 1998, Genes & development.